Evoq Remedies Reports Mixed Half-Year Results Amid Regulatory Scrutiny and Compliance Issues Oct 10, 2025
Evoq Remedies Limited reported revenue of ₹1,175.67 lakhs and profit after tax of ₹5.43 lakhs for the half-year ended September 30. Total assets increased to ₹5,221.50 lakhs. The company faces significant regulatory challenges including a SEBI investigation, failure to implement audit trail software, GST demand of ₹655.03 lakhs, income tax disputes, unconfirmed advances, and non-compliant related party transactions. The auditor, H Thakkar & Co. LLP, has raised concerns about these issues and their potential financial impact.